Stock Earnings

Question 1

Austar Lifesciences Ltdの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Austar Lifesciences Ltdの総資産は$2,083で、純profitは$16です。

Question 2

AULSFの主要な財務比率は何ですか？

Accepted Answer

Austar Lifesciences Ltdの流動比率は1.61、純利益率は1.06、1株当たり売上高は$2.92です。

Question 3

Austar Lifesciences Ltdの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Austar Lifesciences Ltd largest revenue segment is Integrated Process and Packaging Equipment & Systems, at a revenue of 710,388,913 in the most earnings release.For geography, China is the primary market for Austar Lifesciences Ltd, at a revenue of 1,445,798,461.

Question 4

Austar Lifesciences Ltdは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Austar Lifesciences Ltdの純profitは$16です。

Question 5

Austar Lifesciences Ltdに負債はありますか？

Accepted Answer

yes、Austar Lifesciences Ltdの負債は1,292です。

Question 6

Austar Lifesciences Ltdの発行済株式数は何株ですか？

Accepted Answer

Austar Lifesciences Ltdの総発行済株式数は512.58株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,461	1,500	1,763	2,156	2,015	1,295
Revenue Growth (YoY)	-3%	-15%	-18%	7%	56%	23%
Cost of Revenue	1,166	1,199	1,427	1,668	1,536	972
Gross Profit	294	301	336	488	479	323
Selling, General & Admin	238	233	327	299	300	255
Research & Development	46	53	55	70	65	48
Operating Expenses	256	262	377	366	361	296
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	42	21	-34	119	319	41
Income Tax Expense	9	7	0	18	46	9
Net Income	35	16	-113	87	277	33
Net Income Growth	-152%	-113.99%	-229.99%	-69%	739%	313%
Shares Outstanding (Diluted)	512.58	512.58	512.58	512.58	512.58	512.58
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	0.06	0.03	-0.22	0.17	0.54	0.06
EPS Growth	-153%	-113.99%	-229%	-69%	737%	309%
Free Cash Flow	--	78	-131	-155	-204	25
Free Cash Flow Per Share	--	0.15	-0.25	-0.3	-0.39	0.04
Gross Margin	20.12%	20.06%	19.05%	22.63%	23.77%	24.94%
Operating Margin	2.53%	2.53%	-2.32%	5.65%	5.8%	2%
Profit Margin	2.39%	1.06%	-6.4%	4.03%	13.74%	2.54%
Free Cash Flow Margin	--	5.2%	-7.43%	-7.18%	-10.12%	1.93%
EBITDA	--	91	4	161	148	57
EBITDA Margin	--	6.06%	0.22%	7.46%	7.34%	4.4%
D&A For EBITDA	--	53	45	39	31	31
EBIT	37	38	-41	122	117	26
EBIT Margin	2.53%	2.53%	-2.32%	5.65%	5.8%	2%
Effective Tax Rate	21.42%	33.33%	0%	15.12%	14.42%	21.95%

Austar Lifesciences Ltd (AULSF) Price

AULSF Stock Price Chart

AULSF Income

Follow-Up Questions